Skip to content
healthcare.dev

pseudoephedrine hydrochloride

NDC 45802-107, Pseudoephedrine HCl, tablet, film coated, extended release, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-107
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA075153
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-107 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
45802-107-524580201075210 BLISTER PACK in 1 CARTON (45802-107-52) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 45802010752

    GET /v1/drugs/nadac/45802010752

Use it

Look up 45802-107 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-107 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-107. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.